Cancer treatment company plans for public offeringJuly 25, 2019PetCure Oncology has engaged Boustead Securities for a Regulation D 506(c) offering.
SPONSORED CONTENTRedefine defense for your patientsCredelio Quattro is tasty and easy to give. + Learn More